Illuminating drug discovery with biological pathways

被引：82
|
作者：
Apic, G
Ignjatovic, T
Boyer, S
Russell, RB
机构：
[1] Cambridge Cell Networks, Cambridge CB3 0FD, England
[2] AstraZeneca R&D, Safety Assessment, S-43183 Molndal, Sweden
[3] EMBL, D-69112 Heidelberg, Germany
来源：
FEBS LETTERS | 2005年 / 579卷 / 08期
关键词：
systems biology; drug discovery; biological pathways;
D O I：
10.1016/j.febslet.2005.02.023
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Systems biology promises to impact significantly on the drug discovery process. One of its ultimate goals is to provide an understanding of the complete set of molecular mechanisms describing an organism. Although this goal is a long way off, many useful insights can already come from currently available information and technology. One of the biggest challenges in drug discovery today is the high attrition rate: many promising candidates prove ineffective or toxic owing to a poor understanding of the molecular mechanisms of biological systems they target. A "systems" approach can help identify pathways related to a disease and can suggest secondary effects of drugs that might cause these problems and thus ultimately improve the drug discovery pipeline. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：1872 / 1877
页数：6
相关论文
共 50 条
  • [41] The Current Status of Metabolomics in Drug Discovery and Development
    Robertson, Donald G.
    Reily, Michael D.
    DRUG DEVELOPMENT RESEARCH, 2012, 73 (08) : 535 - 546
  • [42] Biosensors in Drug Discovery and Drug Analysis
    Aydin, Elif Burcu
    Aydin, Muhammet
    Sezginturk, Mustafa Kemal
    CURRENT ANALYTICAL CHEMISTRY, 2019, 15 (04) : 467 - 484
  • [43] Drug metabolism and pharmacokinetics in drug discovery
    Roberts, SA
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (01) : 66 - 80
  • [44] Computer-aided drug discovery and development (CADDD):: In silico-chemico-biological approach
    Kapetanovic, I. M.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2008, 171 (02) : 165 - 176
  • [45] Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers
    Carolina C de Oliveira
    Ana Paula R Abud
    Simone M de Oliveira
    Fernando de SF Guimarães
    Lucas F de Andrade
    Raffaello P Di Bernardi
    Ediely L de O Coletto
    Diogo Kuczera
    Eneida J Da Lozzo
    Jenifer P Gonçalves
    Edvaldo da S Trindade
    Dorly de F Buchi
    BMC Complementary and Alternative Medicine, 11
  • [46] NATURAL COMPOUNDS IN DRUG DISCOVERY. BIOLOGICAL ACTIVITY AND NEW TRENDS IN THE CHEMISTRY OF ISOQUINOLINE ALKALOIDS
    V.G. Kartsev
    Medicinal Chemistry Research, 2004, 13 : 325 - 336
  • [47] Drug discovery for type 2 diabetes mellitus and metabolic syndrome: ten novel biological targets
    Tiurenkov, I. N.
    Kurkin, D. V.
    Volotova, E. V.
    Bakulin, D. A.
    Lomkina, E. M.
    DIABETES MELLITUS, 2015, 18 (01): : 101 - 109
  • [48] Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers
    de Oliveira, Carolina C.
    Abud, Ana Paula R.
    de Oliveira, Simone M.
    Guimaraes, Fernando de S. F.
    de Andrade, Lucas F.
    Di Bernardi, Raffaello P.
    Coletto, Ediely L. de O.
    Kuczera, Diogo
    Da Lozzo, Eneida J.
    Goncalves, Jenifer P.
    Trindade, Edvaldo da S.
    Buchi, Dorly de F.
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 11
  • [49] Ayurvedic drug discovery
    Balachandran, Premalatha
    Govindarajan, Rajgopal
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (12) : 1631 - 1652
  • [50] Chemoinformatics and drug discovery
    Xu, J
    Hagler, A
    MOLECULES, 2002, 7 (08): : 566 - 600
12345